BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27458163)

  • 21. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
    Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
    Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
    Vaid M; Sharma SD; Katiyar SK
    Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
    Han HK; Van Anh LT
    Anticancer Res; 2012 Oct; 32(10):4445-52. PubMed ID: 23060571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
    Jiang QQ; Fan LY; Yang GL; Guo WH; Hou WL; Chen LJ; Wei YQ
    BMC Cancer; 2008 Aug; 8():242. PubMed ID: 18706101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
    Chou HC; Lu CH; Su YC; Lin LH; Yu HI; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Chien YA; Yu XR; Lee YR; Chan HL
    Life Sci; 2018 Aug; 207():184-204. PubMed ID: 29883720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
    Kumar A; Kumar Singh U; Chaudhary A
    Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
    Cen M; Yao Y; Cui L; Yang G; Lu G; Fang L; Bao Z; Zhou J
    Cancer Med; 2018 Dec; 7(12):6205-6218. PubMed ID: 30515999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
    BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
    Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
    Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T; Katiyar SK
    Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
    Lee B; Kim CH; Moon SK
    FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
    Dai B; Yan S; Lara-Guerra H; Kawashima H; Sakai R; Jayachandran G; Majidi M; Mehran R; Wang J; Bekele BN; Baladandayuthapani V; Yoo SY; Wang Y; Ying J; Meng F; Ji L; Roth JA
    PLoS One; 2015; 10(6):e0123967. PubMed ID: 26053020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    Howe GA; Xiao B; Zhao H; Al-Zahrani KN; Hasim MS; Villeneuve J; Sekhon HS; Goss GD; Sabourin LA; Dimitroulakos J; Addison CL
    PLoS One; 2016; 11(3):e0150567. PubMed ID: 26962872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
    Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
    Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.
    Kim N; Cho A; Watanabe H; Choi YL; Aziz M; Kassner M; Joung JG; Park AK; Francis JM; Bae JS; Ahn SM; Kim KM; Park JO; Park WY; Ahn MJ; Park K; Koo J; Yin HH; Cho J
    Oncotarget; 2016 Mar; 7(12):13797-809. PubMed ID: 26883194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemopreventive effects of honokiol on UVB-induced skin cancer development.
    Chilampalli S; Zhang X; Fahmy H; Kaushik RS; Zeman D; Hildreth MB; Dwivedi C
    Anticancer Res; 2010 Mar; 30(3):777-83. PubMed ID: 20392996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.
    Chan SS; Zhao M; Lao L; Fong HH; Che CT
    Planta Med; 2008 Mar; 74(4):381-4. PubMed ID: 18484527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.